Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling

• Shuai Xiao,
• Mengyuan Yang,
• Hao Yang,
• Ruimin Chang,
• Feng Fang,
• Lianyue Yang

Affiliations

Shuai Xiao

Liver Cancer Laboratory, Xiangya Hospital, Central South University

Mengyuan Yang

Department of Obstetrics and Gynecology, The Second Xiangya Hospital of Central South University

Hao Yang

Liver Cancer Laboratory, Xiangya Hospital, Central South University

Ruimin Chang

Liver Cancer Laboratory, Xiangya Hospital, Central South University

Feng Fang

Liver Cancer Laboratory, Xiangya Hospital, Central South University

Lianyue Yang

Liver Cancer Laboratory, Xiangya Hospital, Central South University